Renal endothelial dysfunction and hypertension

被引:13
作者
Higashi, Y [1 ]
Chayama, K [1 ]
机构
[1] Hiroshima Univ, Sch Med, Dept Internal Med 1, Cardiovasc Div,Minami Ku, Hiroshima 7348551, Japan
关键词
nitric oxide; L-arginine; renal endothelial function; hypertension;
D O I
10.1016/S1056-8727(01)00202-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with essential hypertension have an impaired endothelium-dependent vascular relaxation in the renal arteries. The possible mechanisms by which essential hypertension is associated with alterations in endothelial function are decreased endothelial nitric oxide (NO) synthase activity, decreased availability or deficiency of L-arginine, increased endogenous NO synthase inhibitor, inactivation of NO by superoxide anions, and increased vasoconstrictors. However, the precise mechanism is not known. In addition, we are now confronted with a difficult question. And the question is whether endothelial dysfunction is a cause or consequence of hypertension. We hypothesize that the initial endothelial dysfunction raises blood pressure, and the development of hypertension impairs much more endothelial function, resulting in constituting the vicious cycle between endothelial dysfunction and hypertension. However, at the moment, it is impossible to answer this question with any certainty. Impairment of endothelial function has been shown to play a critical role in the development and maintenance of hypertension. It is clinically important to select an appropriate intervention that is effective in improving endothelial dysfunction in patients with essential hypertension. Several investigators including us have demonstrated that certain interventions improve endothelial dysfunction of forearm and renal circulation in patients with essential hypertension: angiotensin-converting enzyme inhibitors: lifestyle modification: exercise, body weight reduction, and sodium reduction: estrogen replacement in postmenopausal women: and novel properties: vitamin c and tetrahydrobiopterine. In patients with essential hypertension, endothelial function is impaired in several arteries. However, endothelial dysfunction in essential hypertension is reversible. We can restore endothelial function in essential hypertensive patients. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:103 / 107
页数:5
相关论文
共 50 条
  • [21] Endothelial dysfunction, kidney and hypertension
    Nava, E
    NEFROLOGIA, 1998, 18 : 84 - 89
  • [22] Endothelial vasomotor dysfunction in hypertension
    R Pedrinelli
    Journal of Human Hypertension, 2000, 14 : 481 - 483
  • [23] Endothelial dysfunction in arterial hypertension
    Contreras, F
    Rivera, M
    Vásquez, J
    De la Parte, MA
    Velasco, M
    JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (Suppl 1) : S20 - S25
  • [24] Endothelial dysfunction in arterial hypertension
    F Contreras
    M Rivera
    J Vásquez
    MA De la Parte
    M Velasco
    Journal of Human Hypertension, 2000, 14 : S20 - S25
  • [25] HETEROGENEITY OF ENDOTHELIAL DYSFUNCTION IN HYPERTENSION
    LUSCHER, TF
    EUROPEAN HEART JOURNAL, 1992, 13 : 50 - 55
  • [26] Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease
    Aldamiz-Echevarria, Luis
    Andrade, Fernando
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (09) : 11288 - 11311
  • [27] Renal microvascular dysfunction, hypertension and CKD progression
    Bidani, Anil K.
    Polichnowski, Aaron J.
    Loutzenhiser, Rodger
    Griffin, Karen A.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2013, 22 (01) : 1 - 9
  • [28] 20-hydroxyeicosatetraenoic acid, endothelial dysfunction and hypertension
    Kunert, Mary Pat
    Drenjancevic, Ines
    MEDICINSKI GLASNIK, 2011, 8 (02) : 170 - 180
  • [29] Hypertension and endothelial dysfunction in apolipoprotein E knockout mice
    Yang, RH
    Powell-Braxton, L
    Ogaoawara, AK
    Dybdal, N
    Bunting, S
    Ohneda, O
    Jin, HK
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (11) : 2762 - 2768
  • [30] Endothelial dysfunction in salt-sensitive essential hypertension
    Bragulat, E
    de la Sierra, A
    Antonio, MT
    Coca, A
    HYPERTENSION, 2001, 37 (02) : 444 - 448